Longitudinal performance of polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in large preclinical animal model: 6- versus 12 months

Схожие документы

• Biological performance of a polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in an ovine thoracic interbody fusion model
  по: Yong, Mostyn R N O, et al.
  Опубликовано: (2013)
• The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
  по: A.S. Herford
  Опубликовано: (2017-02-01)
• The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
  по: Herford, A.S.
  Опубликовано: (2017)
• Off-label use of rhBMP-2
  по: Watts, Clark
  Опубликовано: (2011)
• Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Craniofacial Surgery
  по: Ramly, Elie P., et al.
  Опубликовано: (2019)